Cytokines, Chemokines, and Other Biomarkers of Response for Checkpoint Inhibitor Therapy in Skin Cancer.

MLA

Bridge, Jennifer A., et al. “Cytokines, Chemokines, and Other Biomarkers of Response for Checkpoint Inhibitor Therapy in Skin Cancer.” Frontiers in Medicine, vol. 5, Dec. 2018, p. 351. EBSCOhost, https://doi.org/10.3389/fmed.2018.00351.

APA

Bridge, J. A., Lee, J. C., Daud, A., Wells, J. W., & Bluestone, J. A. (2018). Cytokines, Chemokines, and Other Biomarkers of Response for Checkpoint Inhibitor Therapy in Skin Cancer. Frontiers in Medicine, 5, 351. https://doi.org/10.3389/fmed.2018.00351

Chicago

Bridge, Jennifer A, James C Lee, Adil Daud, James W Wells, and Jeffrey A Bluestone. 2018. “Cytokines, Chemokines, and Other Biomarkers of Response for Checkpoint Inhibitor Therapy in Skin Cancer.” Frontiers in Medicine 5 (December): 351. doi:10.3389/fmed.2018.00351.